Fig. 3From: Gender differences in screening for glucose perturbations, cardiovascular risk factor management and prognosis in patients with dysglycaemia and coronary artery disease: results from the ESC-EORP EUROASPIRE surveysProportions and their overlap between screening with different methods [FPG ≥ 7 mmol/L, 2hPG mmol/L ≥ 7.8 mmol/L, HbA1c \(\ge \) 6.5% (48 mmol/mol)] and their combinations in men and women with newly detected dysglycaemia (IGT or T2DM). 2 h-PG 2-h post-load glucose, FPG fasting plasma glucose, HbA1c glycated haemoglobin, IGT impaired glucose tolerance, T2DM type 2 diabetes mellitusBack to article page